The Gordon Research Seminar on Preclinical Form and Formulation for Drug Discovery is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas. The focus of this meeting is on recent progress in understanding and new strategies in preclinical drug development including conventional formulations as well as novel therapies. Discussion topics include, but are not limited to, new approaches in enhancing solubility of poorly-soluble drugs, protein stability, targeted drug delivery, and new analytical methodologies. Additionally, experts in academia and industry will share their experience and provide a general perspective on the future of pharmaceutical research.

1. “Preclinical Form & Formulation
in Drug Discovery”
Date: June 3-4, 2017
Location: Stoweflake Conference
Center Stowe, VT
Chair: Rui Fang
University of Connecticut
Co-Chair: Yinshan Chen
University of Wisconsin
For registration and
other information,
please visitonline
http://www.grc.org/programs.
aspx?id=17085
The Gordon Research
Seminars provide an unique
forum for graduate
students, post-docs and
scientists to discuss frontier
research.
The Gordon Research Seminar on
Preclinical Form & Formulation
for Drug Discovery will be held in
conjunction with the Gordon
Research Conference. The focus
of this meeting is on recent
progress in understanding and
new strategies in drug
development including
conventional formulations as well
as novel therapies. Additionally,
experts will share their
experiences and provide a general
perspective on the future of
pharmaceutical industry.
Oral Presentation deadline:
March 3rd, 2017
Abstract/Application deadline:
May 6th, 2017

2. Saturday, June 3rd 2017
Introductory comments 3:30 – 3:45 pm
Keynote session 3:45 – 4:30 pm
Keynote speaker: Nicholas Warne (Pfizer)
Discussion leader: Narayan Variankaval (Merck)
Poster session I 4:30 – 6:00 pm
Dinner 6:00 – 7:00 pm
Evening session: 7:30 – 9:30 pm
Parenteral formulations - characterization and stability*
Discussion leader: Adora Padilla (GSK Vaccines)
Sunday, June 4th 2017
Breakfast 7:30 – 8:30 am
Morning session: 9:00 – 11:00 am
Oral dosage forms - drug delivery and formulation*
Discussion leader: Sachin Lohani (Johnson & Johnson)
Poster session II 11:00am – 12:30 pm
Lunch 12:30 – 1:30 pm
Career panel discussion 1:30 – 2:30 pm
Panelists:
Annette Bak (AstraZeneca)
Robert Berendt (Food and Drug Administration)
Liz Topp (Purdue University)
Discussion leader: Yongchao Su (Merck)
* Speakers to be selected from submitted abstracts
Preliminary Program